Zdrowie i gospodarka · 29.03.2010

Advisory Committees; Technical Amendment

The Food and Drug Administration (FDA) is amending its regulations on public hearings before public advisory committees to reflect an internal change with respect to the staff that handles the nomination and selection process for nonvoting members representing consumer interests for standing technical advisory committees. FDA is also revising the address where the nominations for nonvoting members representing consumer interests should be submitted.